people reached through global medicine supply networks
A life behind the work
For Guadalupe, access to medicine has never been theoretical.
Born in Zacatecas, Mexico, with severe hemophilia, he learned early what happens when lifesaving medicine exists but remains out of reach. His family immigrated to the United States when he was 13 in search of care. That experience became a lifelong commitment: make healthcare systems work for the people most likely to be left outside them.
His work has taken him from chemistry and literature to health policy, global operations, entrepreneurship, and bioethics.
Watch the story behind the work Guadalupe shares his experience growing up with hemophilia in Mexico and facing barriers to care.Leads the academic Bioethics Program and teaches applied healthcare ethics, combining clinical internships with 23 original case studies.
Brings biopharma leadership experience to three MIT courses covering biopharmaceutical ethics, careers in medicine, and global operations.
Advises NIH’s nearly $1 billion translational research center (FY2026) through its Cures Acceleration Network Review Board, helping accelerate treatments for unmet medical needs.
Built an AI biopharma platform spanning 43 countries, raised $11 million in seed funding, and led the company to acquisition in 2024.
Led 12 clinics delivering free care to 30,000+ underserved patients annually and raised $22 million for healthcare services.
Led medicine supply networks reaching 2.3 billion people across 113 countries; oversaw $2.8 billion in supply spend.
Advises on AI for health emergency preparedness in the 27-member European Union, addressing medicine shortages, demand forecasting, and supply resilience.
Advises on safe, responsible deployment of advanced AI in drug discovery, life sciences, and clinical decision support.